CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-07 | Powell Lynne Senior VP - CCO | Option exercise · Emp. Stock Option (Right to Buy) | −300 | 128,027 | ||
| 2018-11-05 | Powell Lynne Senior VP - CCO | Option exercise | +100 | $3.22 | $322 | 8,705 |
| 2018-11-05 | Powell Lynne Senior VP - CCO | Sale | −100 | $8.00 | $800 | 8,605 |
| 2018-11-05 | Powell Lynne Senior VP - CCO | Option exercise · Emp. Stock Option (Right to Buy) | −100 | 128,327 | ||
| 2018-11-05 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +215 | $3.22 | $692 | 137,598 |
| 2018-11-05 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −215 | $8.00 | $2K | 137,383 |
| 2018-11-05 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −215 | 115,356 | ||
| 2018-11-02 | Powell Lynne Senior VP - CCO | Option exercise | +1,000 | $3.22 | $3K | 9,605 |
| 2018-11-02 | Powell Lynne Senior VP - CCO | Sale | −1,000 | $8.00 | $8K | 8,605 |
| 2018-11-02 | Powell Lynne Senior VP - CCO | Option exercise · Emp. Stock Option (Right to Buy) | −1,000 | 128,427 | ||
| 2018-11-02 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +7,356 | $3.22 | $24K | 144,739 |
| 2018-11-02 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −7,356 | $7.78 | $57K | 137,383 |
| 2018-11-02 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +3,500 | $3.78 | $13K | 140,883 |
| 2018-11-02 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −3,500 | $7.96 | $28K | 137,383 |
| 2018-11-02 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −7,356 | 115,571 | ||
| 2018-11-02 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −3,500 | 45,805 | ||
| 2018-11-01 | Powell Lynne Senior VP - CCO | Sale | −1,544 | $7.51 | $12K | 8,605 |
| 2018-10-19 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +3,150 | $3.78 | $12K | 140,533 |
| 2018-10-19 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −3,150 | $7.45 | $23K | 137,383 |
| 2018-10-19 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −3,150 | 49,305 |
Page 35 of 38 · 750 trades